Even a partial pathological response is associated with lower relapse rates in patients with operable rectal cancer undergoing neoadjuvant chemotherapy.
Michihiro KoizumiTakeshi YamadaSeiichi ShinjiAkihisa MatsudaYasuyuki YokoyamaGoro TakahashiTakuma IwaiKohki TakedaKeisuke HaraHiroshi YoshidaPublished in: Journal of surgical oncology (2020)
Patients whose surgical specimens show a pathological complete response or partial response have good oncologic outcomes.
Keyphrases
- neoadjuvant chemotherapy
- rectal cancer
- locally advanced
- end stage renal disease
- ejection fraction
- lymph node
- newly diagnosed
- chronic kidney disease
- prognostic factors
- sentinel lymph node
- squamous cell carcinoma
- peritoneal dialysis
- type diabetes
- skeletal muscle
- patient reported outcomes
- early stage
- radical prostatectomy
- free survival
- fine needle aspiration